The company carries GLP-related research products, including Semaject and Retaject, with a broader focus on peptide pen formats, domestic fulfillment across Canada, and publicly available batch documentation
How Payer Friction and Patient Drop-Off Undermine Obesity GLP-1 Uptake The GLP-1 market is experiencing unprecedented demand, yet despite its clinical promise for obesity, diabetes, and other conditions, patient behavior and friction throughout the treatment journey continue to erode its commercial potential
Weekly or biweekly schedules are common but timing varies by client needs
Handling: Let frozen vials warm to room temperature before opening so condensation wont form, and keep the solution clear of heat and direct light
Key Takeaways Injectable GLP-1 medications like Mounjaro demonstrate proven weight loss of 15-20%, while patches lack scientific evidence of effectiveness